Clevudine demonstrates potent antiviral activity in naïve chronic hepatitis B patients.

Objectives: Clevudine has demonstrated antiviral potency in the treatment of naïve chronic hepatitis B patients in pivotal studies. The objectives of this study were to evaluate the safety and efficacy of a 1-year treatment with clevudine in chronic hepatitis B patients.

Methods: This is a post-marketing surveillance using case report forms which were submitted to the health authorities.